19 Oct 2019
// BIOSPACE
https://www.biospace.com/article/releases/redhill-biopharma-announces-36-million-strategic-investment-by-cosmo-pharmaceuticals-and-u-s-rights-to-approved-travelers-diarrhea-drug-aemcolo/?s=95
05 Feb 2019
// Derek Lowe SCIENCE MAG BLOG
https://blogs.sciencemag.org/pipeline/archives/2019/02/04/2018-drug-approvals-a-closer-look?r3f_986=https://www.google.com/
21 Nov 2018
// Angus Liu FIERCE PHARMA
https://www.fiercepharma.com/marketing/cosmo-to-give-bausch-health-sales-a-run-latest-fda-nod-for-xifaxan-rival
17 Nov 2018
// FDA
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626121.htm?utm_campaign=FDA%20approves%20new%20treatment%20of%20travelers%E2%80%99%20diarrhea%20caused%20by%20noninvasive%20strains%20of%20Escherichia%20coli&utm_medium=email&utm_source=Eloqua
21 May 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-accepts-new-drug-application-for-aemcolo-rifamycin-sv-mmx-and-sets-pdufa-date-for-november-16-2018-300651877.html
23 Mar 2018
// SEEKINGALPHA
https://seekingalpha.com/article/4158489-valeant-rifamycin-threat-devastating
LOOKING FOR A SUPPLIER?